Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.405 USD | +6.65% | +22.92% | +0.43% |
May. 30 | Sector Update: Health Care Stocks Higher in Afternoon Trading | MT |
May. 30 | Xeris Biopharma Says Potential Levothyroxine Injection Preferred Over Oral Formulation; Shares Rise | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.43% | 334M | |
+41.84% | 739B | |
+32.50% | 598B | |
-5.75% | 353B | |
+17.85% | 318B | |
+3.46% | 285B | |
+16.32% | 240B | |
+9.93% | 210B | |
-5.40% | 206B | |
+6.53% | 164B |
- Stock Market
- Equities
- XERS Stock
- News Xeris Biopharma Holdings, Inc.
- Xeris Biopharma Expects 2023 Revenue to be at High End of Previous Guidance; Shares Jump